Evidence map›Paper›PMID 39563365›Full record

ArticleStem cell research & therapy2024

The wound healing of deep partial-thickness burn in Bama miniature pigs is accelerated by a higher dose of hUCMSCs.

Lingying Liu, Xingxia Hao, Jing Zhang, Shaozeng Li, Shaofang Han, Peipei Qian, Yong Zhang, Huaqing Yu, Yuxin Kang, Yue Yin and 7 more

Abstract read
In one paragraph

Article in Stem cell research & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Lingying Liu *Department of Nutrition, The Fourth Medical Center Affiliated to PLA General Hospital, No. 51 Fucheng Road, Haidian District, Beijing, 100037, China. liulingyingyisheng@163.com.ORCID 0000-0001-9023-1424
Xingxia Hao *Inner Mongolia Medical University, Hohhot, Inner Mongolia, 010110, China.
Jing Zhang *Inner Mongolia Medical University, Hohhot, Inner Mongolia, 010110, China.
Shaozeng Li *Department of Clinical Laboratory, The Fourth Medical Center Affiliated to PLA General Hospital, Beijing, 100037, China.
Shaofang HanDepartment of Nutrition, The Fourth Medical Center Affiliated to PLA General Hospital, No. 51 Fucheng Road, Haidian District, Beijing, 100037, China.
Peipei QianDepartment of Nutrition, The Fourth Medical Center Affiliated to PLA General Hospital, No. 51 Fucheng Road, Haidian District, Beijing, 100037, China.
Yong ZhangDepartment of Nutrition, The Fourth Medical Center Affiliated to PLA General Hospital, No. 51 Fucheng Road, Haidian District, Beijing, 100037, China. zhy-545@163.com.ORCID 0000-0001-9650-4294
Huaqing YuDepartment of Nutrition, The Fourth Medical Center Affiliated to PLA General Hospital, No. 51 Fucheng Road, Haidian District, Beijing, 100037, China.
Yuxin KangHebei North University, Zhangjiakou, Hebei, 075000, China.
Yue YinInner Mongolia Medical University, Hohhot, Inner Mongolia, 010110, China.
Weiouwen ZhangDepartment of Nutrition, The Fourth Medical Center Affiliated to PLA General Hospital, No. 51 Fucheng Road, Haidian District, Beijing, 100037, China.
Jianmei ChenDepartment of Health Medicine, The Fourth Medical Center of Chinese PLA General Hospital, Beijing, 100037, China.
Yang YuDepartment of Traditional Chinese Medical Science, The Sixth Medical Center of the Chinese PLA General Hospital, Beijing, China.
Hua JiangDepartment of Endocrinology, The Fourth Medical Center of Chinese PLA General Hospital, Beijing, China.
Jiake ChaiSenior Department of Burns and Plastic Surgery, The Fourth Medical Center of PLA General Hospital, Beijing, 100037, China.
Huinan YinSenior Department of Burns and Plastic Surgery, The Fourth Medical Center of PLA General Hospital, Beijing, 100037, China.
Wei ChaiSenior Department of Orthopedics, The Fourth Medical Center of PLA General Hospital, Beijing, 100037, China.

Funding

National Natural Science Foundation of China 81701900National Natural Science Foundation of China U22A20355Youth Independent Innovation Science Foundation of PLA General Hospital 22QNCZ031
6 · The paper itself

Abstract

backgroundDeep partial-thickness burns have a significant impact on both the physical and mental health of patients. Our previous study demonstrated human Umbilical Cord Mesenchymal stem cells (hUCMSCs) could enhance the healing of severe burns in small animal burn models, such as rats. Furthermore, our team has developed a deep partial-thickness burn model in Bama miniature pigs, which can be utilized for assessing drug efficacy in preclinical trials for wound healing. Therefore, this study further determine the optimal dosage of hUCMSCs in future clinical practice by comparing the efficacy of low-to-high doses of hUCMSCs on deep partial-thickness burn wounds in Bama miniature pigs. MATERIALS AND

methodsThe male Bama miniature pigs (N = 8, weight: 23-28 kg and length: 71-75 cm) were used to establish deep partial-thickness burn models, which used a continuous pressure of 1 kg and contact times of 35 s by the invented electronic burn instrument at 100℃ to prepare 10 round burn wounds with diameter of 5 cm according to our previous report. And then, 0 × 10^7, 1 × 10^7, 2 × 10^7, 5 × 10^7 and 1 × 10^8 doses of hUCMSCs were respectively injected into burn wounds of their corresponding groups. After treatment for 7, 14 and 21 days, the burned wound tissues were obtained for histological evaluation, including HE staining for histopathological changes, immunohistochemistry for neutrophil (MPO+) infiltration and microvessel (CD31+) quantity, as well as Masson staining for collagen deposition. The levels of inflammatory factors TNF-α, IL-1β, IL-10 and angiogenesis factors angiopoietin-2 (Ang-2), vascular endothelial growth factor (VEGF), as well as collagen type-I/type-III of the wound tissues were quantified by ELISA.

resultsAll of doses hUCMSCs can significantly increase wound healing rate and shorten healing time of the deep partial-thickness burn pigs in a dose-dependent manner. Furthermore, all of doses hUCMSCs can significantly promote epithelialization and decreased inflammatory reaction of wound, including infiltration of inflammatory cells and levels inflammatory factors. Meanwhile, the amounts of microvessel were increased in all of doses hUCMSCs group than those in the burn group. Furthermore, the collagen structure was disordered and partially necrotized, and ratios of collagen type-I and type-III were significantly decreased in burn group (4:1 in normal skin tissue), and those of all hUCMSCs groups were significantly improved in a dose-dependent manner. In a word, 1 × 10^8 dose of hUCMSCs could regenerate the deep partial-thickness burn wounds most efficaciously compared to other dosages groups and the burn group.

conclusionThis regenerative cell therapy study using hUCMSCs demonstrates the best efficacy toward a high dose, that is dose of 1 × 10^8 of hUCMSCs was used as a reference therapeutic dose for treating 20 cm

Indexed as

BurnsMesenchymal Stem CellsMesenchymal Stem Cell TransplantationSwine, MiniatureWound HealingAnimalsDisease Models, AnimalHumansMaleSwineUmbilical CordAngiogenesisBurn woundCollagenInflammationMSCs

Identifiers

PMID39563365
PMCPMC11575178

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.